🚀 Pharmidex In Silico Drug Discovery – Step 4: Molecular Docking! 🔬💻
February 26, 2025

Pharmidex continues advancing computational drug discovery! After identifying active/binding sites, our Molecular Docking step ensures precise interaction analysis between potential drug candidates and target proteins, streamlining lead optimization.


✨ Why is this step key?

✅ Predicts binding affinity and stability of drug candidates

✅ AI-enhanced docking for high-precision molecular interactions

✅ Accelerates hit-to-lead identification with accurate simulations

✅ Seamlessly integrates with the next in silico pipeline steps


By combining cutting-edge modeling and expert-driven analysis, we de-risk drug development and fast-track novel therapeutic discoveries.


📽️ Watch our latest video (3/5) showcasing how we refine drug-target interactions through Molecular Docking!


📩 Let’s collaborate to transform drug discovery!


#DrugDiscovery #Pharmidex #AIinBiotech #MolecularDocking #PharmaceuticalInnovation

December 16, 2025
We are pleased to share that Ian Knowles and Martin Barrett will attend Pharmacology 2025, organized by The British Pharmacological Society (BPS), at the ICC Belfast from 16–18 December 2025. They will host a Pharmidex exhibition stand, showcasing our key services and their importance in drug discovery and development. Ian and Martin will be delighted to meet attendees, exchange ideas, and explore new collaboration opportunities. Come and say hello!
December 8, 2025
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.
December 3, 2025
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!
More Posts